Skip to content

The Effect of Exercise on Wound Healing While Off-loading

The Effect of Exercise on Wound Healing in People With Diabetes Undergoing Off-loading Treatment

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04280016
Enrollment
15
Registered
2020-02-21
Start date
2021-05-14
Completion date
2023-05-31
Last updated
2021-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot Ulcer

Keywords

Diabetes, off-loading, exercise

Brief summary

This study seeks to establish the effect of adding exercise to off-loading interventions on the healing time for people with diabetes mellitus and a foot ulcer. Hypothesis: Consistent with the literature, results are expected to resemble the accelerated healing seen when older adults exercised in the presence of wounds.

Detailed description

The purpose of this project is to establish the effect of the addition of exercise to an off-loading intervention on the healing time for people with diabetes mellitus and a foot ulcer. While benefits of physical activity and exercise are clear, the benefit of exercise on wound healing in individuals with diabetes has not been elucidated. It is critical to better understand how prescribed exercise effects the healing speed in patients receiving wound care with appropriate off-loading. If exercise does decrease healing time, the benefit to the patient may include lower cost, decreased risk of infection, decreased burden on a caregiver, and improved quality of life.

Interventions

BEHAVIORALExercise

Participants will participate in an exercise session with non-weight-bearing exercise that the participant is able to perform with off-loading (e.g. total contact cast) intact. They will also be instructed in a home exercise program so that exercise can be performed three days per week with no more than two days between sessions. These participants will also receive standard wound care with off-loading.

Sponsors

Mercer University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

The outcome assessor will be unaware of how much the participant participated in the exercise program. Exercise will occur away from the treatment area so that the care provider will be unaware of whether or not a patient is participating in the study.

Intervention model description

A pilot study using retrospective chart review and non-randomized controlled trial methodology (single group).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have diabetes * Have an active plantar ulceration * With or without peripheral neuropathy * Able to safely exercise * Receiving care for their plantar ulceration, including off-loading

Exclusion criteria

\- Presence of an untreated infection, osteomyelitis, or gangrene

Design outcomes

Primary

MeasureTime frameDescription
Wound measurement sizeMeasurements of wound will be taken up to 12 weeks or until wound closure occurs, whichever is first.Charts will be reviewed for normal wound measurements as is part of standard care. Measurements are expected to be reported as surface area (cm\^2) and/or volume (cm\^3). Wound closure will be defined as epithelialization across the entire wound bed and would be expected to correlate to no surface area or volume of wound being reported.

Secondary

MeasureTime frameDescription
Summary of Diabetes Self-Care Activities ScaleMeasurement will be taken at baseline and at end of study (at 12 weeks or at wound closure, whichever occurs first).Participation in exercise. Using two questions, this scale measures the number of days that an individual reports doing physical activity (question 1) or specific exercise (question 2). Scores on each question could range from 0 to 7 days. The higher the number, the more days the individual participates in the activity or exercise.
Body Mass IndexMeasurement will be taken at baseline and at end of study (at 12 weeks or at wound closure, whichever occurs first).Height and weight measurements will be combined and reported as BMI and measured in kg/m\^2.
Physical activity data using an activity monitor (e.g. StepWatch).Measured at baseline for one week.A week-long measurement of strides will be taken at the begin of the study.
Vibration senseMeasurement will be taken at baseline and at end of study (at 12 weeks or at wound closure, whichever occurs first).Vibration sense will be measured using a Bio-Thesiometer to assess for degree of peripheral neuropathy. A higher score would indicate decreased sensory perception of vibration.
Waist circumferenceMeasurement will be taken at baseline and at end of study (at 12 weeks or at wound closure, whichever occurs first).Waist circumference will be taken in cm as a marker of body composition.

Countries

United States

Contacts

Primary ContactDeborah M. Wendland, PhD
wendland_dm@mercer.edu6785476775
Backup ContactTeri Biven, DPT
Teri.Biven@piedmont.org404.605.2743

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026